JPMORGAN CHASE & CO - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$88,500
+17.9%
59,0000.0%0.00%
Q2 2023$75,058
+477.4%
59,000
+490.0%
0.00%
Q1 2023$13,000
-99.1%
10,000
-99.1%
0.00%
Q2 2022$1,433,000
+620.1%
1,076,000
+607.9%
0.00%
Q1 2022$199,000
-47.8%
152,000
-50.0%
0.00%
Q4 2021$381,000
+3075.0%
304,000
+3277.8%
0.00%
Q3 2021$12,000
-99.8%
9,000
-99.8%
0.00%
-100.0%
Q1 2021$5,494,000
+13.1%
4,053,000
+15.5%
0.00%0.0%
Q4 2020$4,858,000
+104.1%
3,508,000
+105.5%
0.00%
Q3 2020$2,380,000
-18.6%
1,707,000
-2.9%
0.00%
-100.0%
Q2 2020$2,923,000
+16.2%
1,758,000
-10.6%
0.00%0.0%
Q1 2020$2,515,000
-55.5%
1,966,000
-46.7%
0.00%0.0%
Q4 2019$5,652,000
-7.9%
3,686,000
-17.9%
0.00%0.0%
Q3 2019$6,137,000
+39.5%
4,487,000
+32.8%
0.00%0.0%
Q2 2019$4,399,000
+21.3%
3,379,000
+23.5%
0.00%0.0%
Q1 2019$3,626,000
+206.2%
2,736,000
+174.7%
0.00%
Q4 2018$1,184,000
-71.1%
996,000
-58.3%
0.00%
-100.0%
Q3 2018$4,096,000
+29.5%
2,386,000
+9.8%
0.00%0.0%
Q2 2018$3,164,0002,174,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders